Enabling Democratization of Clinical Trial Data Within NovartisThe contrast between the clinical trial data’s insight value and its high sensitivity means that a clear policy is needed to manage the…Oct 4, 2022Oct 4, 2022
UPDATED: Introducing the “Inside data42” blog series: Learnings and insights from building a world…UPDATE: Adding a new story to the series:Sep 14, 2022Sep 14, 2022
